Posts

Showing posts with the label IPCA Laboratories share price

Stock picks of the week: Stock picks of the week: 5 stocks with consistent score improvement and upside potential of more than 33% in 1 year

Image
[hfe_template id='11223'] [ad_1] Synopsis Back in September 2024, who would have thought that bulls would vanish from the street in just six months, and bears would rule? But markets going through cycles and corrective phases is normal. The best way to deal with such times of global uncertainty is to be calm and review your portfolio. If required, book some losses in poor stocks. Clean up your portfolio so that when the bulls return, your returns are better. Look at the fundamentals, and if there is business growth over the long term, just ignore the noise. Our selected stocks for today depict a strong upward trajectory in their overall average score which is based on five key pillars: Earnings, fundamentals, relative valuation, risk, and price momentum. This implies that there has been a significant improvement in their market outlook in the given time frame. Stories of courage in the face of adversity are always thrilling. Till, that is, you find yourself in a similar ...

Pharma sector stocks to buy: A Trump tariff tantrum-proof sector? 8 stocks from pharma sector, where Democrats and Republicans are in agreement, with an upside potential of up to 34% in 1 year

Image
[hfe_template id='11223'] [ad_1] Synopsis When Donald Trump is back in the saddle, one thing is certain: Tariff wars. Yes, China will be the biggest target. But for all those who think India will be unaffected, just do a Google search for “Trump on high import duty on Harley Davidson bikes”. A further indication came just a few days ago when he mentioned Brazil and India in the same breath, saying that the two countries were imposing high tariffs and should expect consequences. While it may not become a major issue, there may well be some retaliation. Or the threat of retaliation could be used as a tool to get India to change its stance on some global issue. Or as a quid pro quo: For instance, a push for lower duties on EVs, especially cars – a move that could help Trump’s biggest backer Elon Musk and his Tesla. But one sector which would be relatively safe could be pharma, and there are reasons for it. And mind you, we are using the word “relatively”. As the world gets ...